JP2011506941A5 - - Google Patents

Download PDF

Info

Publication number
JP2011506941A5
JP2011506941A5 JP2010537302A JP2010537302A JP2011506941A5 JP 2011506941 A5 JP2011506941 A5 JP 2011506941A5 JP 2010537302 A JP2010537302 A JP 2010537302A JP 2010537302 A JP2010537302 A JP 2010537302A JP 2011506941 A5 JP2011506941 A5 JP 2011506941A5
Authority
JP
Japan
Prior art keywords
seprase
cancer
esophagus
colon
stomach
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010537302A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011506941A (ja
JP5563988B2 (ja
Filing date
Publication date
Priority claimed from EP07023897A external-priority patent/EP2071337A1/en
Application filed filed Critical
Priority claimed from PCT/EP2008/010385 external-priority patent/WO2009074275A1/en
Publication of JP2011506941A publication Critical patent/JP2011506941A/ja
Publication of JP2011506941A5 publication Critical patent/JP2011506941A5/ja
Application granted granted Critical
Publication of JP5563988B2 publication Critical patent/JP5563988B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010537302A 2007-12-10 2008-12-08 癌のマーカーとしてのセプラーゼ Expired - Fee Related JP5563988B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP07023897.7 2007-12-10
EP07023897A EP2071337A1 (en) 2007-12-10 2007-12-10 Seprase as a marker for cancer
EP08015310 2008-08-29
EP08015310.9 2008-08-29
PCT/EP2008/010385 WO2009074275A1 (en) 2007-12-10 2008-12-08 Seprase as a marker for cancer

Publications (3)

Publication Number Publication Date
JP2011506941A JP2011506941A (ja) 2011-03-03
JP2011506941A5 true JP2011506941A5 (https=) 2011-10-06
JP5563988B2 JP5563988B2 (ja) 2014-07-30

Family

ID=40373548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010537302A Expired - Fee Related JP5563988B2 (ja) 2007-12-10 2008-12-08 癌のマーカーとしてのセプラーゼ

Country Status (14)

Country Link
US (1) US8980573B2 (https=)
EP (1) EP2223115B1 (https=)
JP (1) JP5563988B2 (https=)
KR (1) KR101202220B1 (https=)
CN (1) CN101896818B (https=)
AT (1) ATE524740T1 (https=)
AU (1) AU2008335855B2 (https=)
BR (1) BRPI0820793A2 (https=)
CA (1) CA2706115A1 (https=)
DK (1) DK2223115T3 (https=)
ES (1) ES2372442T3 (https=)
MX (1) MX2010004671A (https=)
PL (1) PL2223115T3 (https=)
WO (1) WO2009074275A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8213005B2 (en) 2003-07-22 2012-07-03 King Saud University Method for discriminating between benign and malignant prostate tumors
CA2728153C (en) * 2008-07-03 2015-01-27 F. Hoffmann-La Roche Ag Asc as a marker for lung cancer
JP5763098B2 (ja) 2009-12-20 2015-08-12 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
PT2666872T (pt) 2010-02-05 2016-07-08 Astute Medical Inc Processos e composições para o diagnóstico e o prognóstico de lesões renais e de insuficiência renal
AU2011316986A1 (en) * 2010-10-20 2013-06-06 Rush University Medical Center Lung cancer tests
EP2684051B1 (en) 2011-03-11 2016-04-27 Roche Diagniostics GmbH Asc as marker for chronic obstructive pulmonary disease (copd)
JP2014509736A (ja) * 2011-03-11 2014-04-21 エフ.ホフマン−ラ ロシュ アーゲー 慢性閉塞性肺疾患(copd)のマーカーとしてのセプラーゼ
CN102435748B (zh) * 2011-11-25 2014-07-16 广东药学院 一种双抗夹心酶联免疫检测试剂盒及其制备方法
ES2734494T3 (es) 2011-12-08 2019-12-10 Astute Medical Inc Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal
CA2877721A1 (en) 2012-06-27 2014-01-03 Berg Llc Use of markers in the diagnosis and treatment of prostate cancer
CA2891028C (en) 2012-11-09 2017-02-07 F. Hoffmann-La Roche Ag In vitro capture and analysis of circulating tumor cells
SG11201504241QA (en) * 2012-11-30 2015-06-29 Applied Proteomics Inc Method for evaluation of presence of or risk of colon tumors
TR201807542T4 (tr) 2013-01-17 2018-06-21 Astute Medical Inc Böbrek hasarı ve böbrek yetmezliği teşhisi ve prognozuna yönelik metotlar ve bileşimler.
US9753037B2 (en) 2013-03-15 2017-09-05 Rush University Medical Center Biomarker panel for detecting lung cancer
CN103267852B (zh) * 2013-05-15 2015-03-25 中国医学科学院北京协和医院 成纤维激活蛋白α在制备胰腺癌预后试剂盒中的用途
KR101619122B1 (ko) 2013-08-14 2016-05-10 연세대학교 산학협력단 탈메틸화 의존적 asc 발현을 촉진시켜서 대장암 종양세포의 사멸감수성을 증진시키는 항암제 병용 투여용 후보물질의 스크리닝 방법
EP3080299B1 (en) 2013-12-09 2020-09-30 Rush University Medical Center Biomarkers of rapid progression in advanced non-small cell lung cancer
PL230661B1 (pl) * 2014-01-29 2018-11-30 Centrum Onkologii Inst Im Marii Sklodowskiej Curie Oddzial W Gliwicach Metoda predykcyjna in vitro do przewidywania i/lub wykluczenia obecnosci raka pluc, zastosowanie in vitro metody predykcyjnej oraz zestaw testowy do wykrywania in vitro raka pluc
EP2916134B1 (en) * 2014-03-05 2017-08-16 Roche Diagnostics GmbH Use of Seprase for differential diagnosis of acute dyspnea
US10539566B2 (en) 2014-12-08 2020-01-21 Berg Llc Use of markers including filamin A in the diagnosis and treatment of prostate cancer
WO2016146174A1 (en) * 2015-03-17 2016-09-22 Biontech Ag Compositions and methods for diagnosis and treatment of cancer
WO2016164815A1 (en) 2015-04-10 2016-10-13 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
JP2018035137A (ja) 2016-07-13 2018-03-08 マブイミューン ダイアグノスティックス エイジーMabimmune Diagnostics Ag 新規な抗線維芽細胞活性化タンパク質(fap)結合薬剤およびその使用
WO2018020530A1 (ja) * 2016-07-25 2018-02-01 静岡県 肝外胆管癌、肝内胆管癌、又は胆嚢癌の診断用バイオマーカー
CN116474108A (zh) 2016-12-14 2023-07-25 普渡研究基金会 成纤维细胞活化蛋白(fap)-靶向成像和治疗
DE102017010455A1 (de) * 2017-06-13 2018-12-13 Forschungszentrum Jülich GmbH Verfahren zum Nachweis von Aggregaten biotherapeutischer Substanzen in einer Probe
CA3074684A1 (en) * 2017-09-05 2019-03-14 Oncotag Diagnostics Co., Ltd. Method for diagnosing pancreatic cancer using methionyl-trna synthetase, and pancreatic cancer diagnostic kit using same
CN112540176B (zh) * 2020-07-08 2021-09-28 深圳霁因生物医药转化研究院 用于诊断fap表达异常相关疾病的试剂盒、方法及计算机可读存储介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0953639A1 (en) * 1998-04-30 1999-11-03 Boehringer Ingelheim International GmbH FAPalpha-specific antibody with improved producibility
CN1922304A (zh) 2003-10-31 2007-02-28 维特克公司 用于检测循环肿瘤和内皮细胞的血液测试样机和方法
CN101048426A (zh) * 2004-10-22 2007-10-03 金克克国际有限公司 分离人抗体
EP1760076A1 (en) * 2005-09-02 2007-03-07 Ferring B.V. FAP Inhibitors
JP5270369B2 (ja) * 2005-12-19 2013-08-21 タフツ ユニバーシティー/トラスティーズ オブ タフツ カレッジ ソフトプロテアーゼ抑制剤およびそのプロソフト型

Similar Documents

Publication Publication Date Title
JP2011506941A5 (https=)
US20230116530A1 (en) Method for detecting nucleosomes containing histone variants
Wang et al. Detection of prostate specific antigen in whole blood by microfluidic chip integrated with dielectrophoretic separation and electrochemical sensing
Gao et al. Multiplexed detection of lung cancer biomarkers in patients serum with CMOS-compatible silicon nanowire arrays
Lim et al. An electrochemical peptide sensor for detection of dengue fever biomarker NS1
JP2011506917A5 (https=)
DK2751568T3 (en) METHOD FOR DETECTING NUCLEOSOMES CONTAINING NUCLEOTIDES
Qi et al. An overview of esophageal squamous cell carcinoma proteomics
CN113767289A (zh) 结直肠癌筛选检查及早期检测方法
WO2006036788A3 (en) Methods and compositions for evaluating breast cancer prognosis
Jainish et al. Biosensors and biomarkers: promising tools for cancer diagnosis
JP2014531573A5 (https=)
JP2023545017A5 (https=)
CN103097548A (zh) 基于多癌症侵袭相关机制的生物标记
JP2013521763A5 (https=)
WO2008151110A3 (en) Molecular diagnosis and typing of lung cancer variants
JP2008530582A5 (https=)
Wang et al. MXenes-Au NPs modified electrochemical biosensor for multiple exosome surface proteins analysis
Reis et al. A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors
Peng et al. Circulating cell-free mtDNA as a new biomarker for cancer detection and management
JP2020514689A5 (https=)
Mostufa et al. Giant magnetoresistance based biosensors for cancer screening and detection
Lin et al. An enzyme-free fluorescent biosensor for highly sensitive detection of carcinoembryonic antigen based on aptamer-induced entropy-driven circuit
Wang et al. An ultrasensitive label-free electrochemical impedimetric immunosensor for vascular endothelial growth factor based on specific phage via negative pre-screening
Chen et al. Electrochemical identification of hepatocellular carcinoma based on the assay of human cervical cancer oncoprotein-1 in serum